Anteris Technologies Global (AVR) Stock Price, News & Analysis

Company Overview

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Key Stats

• Today's Range: $3.85 to $4.06
• 50-Day Range: $2.90 to $4.15
• 52-Week Range: $2.34 to $8.79
• Volume: 76,428 shs
• Average Volume: 201,119 shs
• Market Capitalization: $144.24 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.50
• Consensus Rating: Buy

Anteris Technologies Global Stock Analysis - MarketRank™

Anteris Technologies Global scored higher than 35% of companies evaluated by MarketBeat, and ranked 751st out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Anteris Technologies Global has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Anteris Technologies Global has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Anteris Technologies Global are expected to grow in the coming year, from ($2.66) to ($1.89) per share.

Price to Book Value per Share Ratio

Anteris Technologies Global has a P/B Ratio of 2.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for AVR.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Anteris Technologies Global does not currently pay a dividend.

Dividend Growth

Anteris Technologies Global does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for AVR.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 1.75

News Sentiment

Anteris Technologies Global has a news sentiment score of 1.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.13 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Anteris Technologies Global this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Anteris Technologies Global insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 4.00% of the stock of Anteris Technologies Global is held by insiders.

AVR Stock Analysis - Frequently Asked Questions

How have AVR shares performed this year?

Anteris Technologies Global's stock was trading at $5.58 at the beginning of 2025. Since then, AVR stock has decreased by 29.0% and is now trading at $3.96.

How were Anteris Technologies Global's earnings last quarter?

Anteris Technologies Global Corp. (NASDAQ:AVR) posted its quarterly earnings results on Monday, August, 11th. The company reported ($0.58) EPS for the quarter, missing the consensus estimate of ($0.53) by $0.05. The firm had revenue of $0.62 million for the quarter, compared to analysts' expectations of $0.58 million.

When did Anteris Technologies Global IPO?

Anteris Technologies Global (AVR) raised $89 million in an initial public offering (IPO) on Friday, December 13th 2024. The company issued 14,800,000 shares at $6.00 per share.

Who are Anteris Technologies Global's major shareholders?

Top institutional investors of Anteris Technologies Global include L1 Capital Pty Ltd (7.80%), Sio Capital Management LLC (5.10%), Perceptive Advisors LLC (4.73%) and Nantahala Capital Management LLC (4.70%).

How do I buy shares of Anteris Technologies Global?

Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/11/2025
• Today: 9/02/2025
• Next Earnings (Estimated): 11/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AVR
• Previous Symbol: NASDAQ:AVR
• CIK: 2011514
• Web: N/A
• Phone: (651) 493-0606
• Fax: N/A
• Employees: 138
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Anteris Technologies Global: $16.50
• High Price Target: $22.00
• Low Price Target: $9.00
• Potential Upside/Downside: +316.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.41
• Quick Ratio: 2.38

Sales & Book Value

• Annual Sales: $2.70 million
• Price / Sales: 52.89
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.74 per share
• Price / Book: 2.28

Miscellaneous

• Outstanding Shares: 36,060,000
• Free Float: 34,620,000
• Market Cap: $142.80 million
• Optionable: N/A
• Beta: N/A